NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers

Post time The day before yesterday 17:12

journal：Cell Chemical Biology

Authors：Xiaotong Zhu; Ye Li; Haixia Liu; Yuetong Wang; Renhong Sun; Zhenzhou Jiang; Chun Hou; Xianyu Hou; Suming Huang; Huijuan Zhang; Haopeng Wang; Biao Jiang; Xiaobao Yang; Bin Xu; Gaofeng Fan

Published date：2024-6-

DOI：10.1016/j.chembiol.2024.05.007

PDF link：https://www.sciencedirect.com/sc ... 451945624002083/pdf

Article link：http://dx.doi.org/10.1016/j.chembiol.2024.05.007

Article Source：Elsevier BV。

Remark：

Post time The day before yesterday 17:12

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers